Latest Mitochon Pharmaceuticals News & Updates

See the latest news and media coverage for Mitochon. We track all announcements, press releases, and industry mentions in real time, all in one place.

Mitochon Pharmaceuticals (Mitochon)

Clinical-stage biotech developing mitochondria-targeting drugs

mitochonpharma.com

Headquarters: Blue Bell, United States
Founded year: 2014
Company type: Private company
Number of employees: 4–10
Industry: Biotechnology & Medical Research

Last updated Today

Latest news about Mitochon Pharmaceuticals (Mitochon)

In short: Mitochon received a $1 million grant to fund Phase II clinical trials of its ALS drug MP-101 after successful early-stage testing.

Company announcements

August 31 Mitochon

Mitochon receives $1 million award for ALS drug trials

The funding supports a Phase II study of MP-101, targeting mitochondrial dysfunction to halt neurodegeneration.

August 20 Mitochon

Mitochon receives one million dollars for Phase II ALS research

The grant funds a 24-week clinical trial evaluating MP-101 for sporadic disease, building on prior European data showing rapid neurofilament reduction.

April 30 Mitochon

Mitochon Pharmaceuticals repurposes DNP for brain treatments

MP101 and MP201 modulate mitochondria for neuroprotection, mimicking fasting benefits and inducing BDNF for cognition and neural growth.

February 24 Mitochon

Mitochon Pharmaceuticals completes promising ALS drug trial

Early-stage European study with 18 patients over two weeks shows signs of slowing disease progression by stabilizing mitochondria. One patient regained ability to button shirt.

Media coverage

August 20 Yahoo Finance

Mitochon Pharmaceuticals Announces $1 Million Award From ALS Association for Phase II Clinical Study

Mitochon Pharmaceuticals is pleased to announce the receipt of a $1 million Hoffman ALS Clinical Trial Award from the ALS Association. This funding will pave...

August 17 Benzinga

Amylyx Pharmaceuticals Stock Soars After the Close: Here's Why - Amylyx Pharmaceuticals (NASDAQ:AMLX) - Benzinga

Amylyx Pharmaceuticals shares are trading higher Monday after the company scheduled a Phase 3 trial results readout for this week.

May 18 The Manila Times

Nexentis Announces MitoCareX Bio Achieves Key R&D Milestone, Generating a Substantially Improved Hit Molecule on the Path to Pre-Clinical Development | The Manila Times

MITOLINE® - the U.S. ... in mitochondrial drug discovery: the near-total absence of experimentally solved 3D structures for this important protein class. The initial hit...

February 12 Technical.ly

ALS drug trial shows promising signs for Philly-area startup's once-daily pill

A Blue Bell startup is studying whether stabilizing mitochondria can slow progression in neurodegenerative disease.

Never miss news about Mitochon

Track Mitochon and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Mitochon competitors & trending companies

Browse news for competitors to Mitochon and other trending companies.